These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 13832608

  • 1. [Iproniazid, a monoamino oxidase inhibitor. Its use in psychiatry and cardiology].
    SOLIGNAC H.
    Rev Prat; 1960 Mar 01; 10():773-81. PubMed ID: 13832608
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Iproniazid in psychiatry].
    ARRUDA E, de ARRUDA RA, CASTANHEIRA JA.
    Hospital (Rio J); 1959 Aug 01; 56():265-79. PubMed ID: 13794522
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Twenty month study of iproniazid therapy.
    JOEL SW.
    Dis Nerv Syst; 1959 Nov 01; 20():521-4. PubMed ID: 14407353
    [No Abstract] [Full Text] [Related]

  • 7. Nialamide in the private practice of psychiatry.
    KLINE NS.
    Dis Nerv Syst; 1959 Oct 01; 20():482-8. PubMed ID: 14409888
    [No Abstract] [Full Text] [Related]

  • 8. [Iproniazid in psychiatric therapeutics].
    INSUA JA, BERARD E.
    Presse Med (1893); 1959 Aug 01; 67():1458-9. PubMed ID: 13852909
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical observations on the use of iproniazid in tuberculous psychopaths].
    AGRESTI E.
    Riv Patol Nerv Ment; 1959 Aug 01; 80():383-5. PubMed ID: 13792067
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of marsilid in psychiatric disorders].
    MOUSSONG-KOVACS E.
    Orv Hetil; 1960 Aug 14; 101():1180-2. PubMed ID: 14424789
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical experiences with iproniazid and additional monoamine oxidase inhibitors with analogous effects].
    VOELKEL A.
    Psychiatr Neurol (Basel); 1960 Jul 14; 140():83-8. PubMed ID: 13781777
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical effects of Marsilid and its EEG evaluation].
    KRONBERGEROVA J, JANIK A.
    Act Nerv Super (Praha); 1962 Jul 14; 4():229. PubMed ID: 14459822
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapy of psychic diseases with iproniazid (marsilid)].
    SCHAEPPERLE O.
    Nervenarzt; 1959 Dec 20; 30():557-61. PubMed ID: 14442364
    [No Abstract] [Full Text] [Related]

  • 16. [Apropos of the action of iproniazid on certain metabolic myocardoses].
    ARROYO H, BERNARD A.
    Presse Med (1893); 1961 Mar 18; 69():586. PubMed ID: 14448384
    [No Abstract] [Full Text] [Related]

  • 17. [Remarks on the use of a new psychotonic agent: iproniazid].
    OULES J, LABAI C.
    Toulouse Med; 1960 Oct 18; 61():697-704. PubMed ID: 13731722
    [No Abstract] [Full Text] [Related]

  • 18. The usefulness of amine oxidase inhibitors in psychiatry.
    FRAZIER SH, FAUCETT RL.
    Ann N Y Acad Sci; 1959 Sep 17; 80():754-9. PubMed ID: 13824671
    [No Abstract] [Full Text] [Related]

  • 19. [Iproniazid; biochemistry, activity and use in psychiatry].
    COULLAUT R, CHICATA MA, MORON J.
    Rev Clin Esp; 1960 Jan 31; 76():97-103. PubMed ID: 13812353
    [No Abstract] [Full Text] [Related]

  • 20. The effects of iproniazid and other amine oxidase inhibitors in rheumatoid arthritis.
    SCHERBEL AL, HARRISON JW.
    Ann N Y Acad Sci; 1959 Sep 17; 80():820-34. PubMed ID: 14442641
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.